Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction

Circulation

Volumn 104, Issue 13, 2001, Pages 1489-1493

  Veenhuyzen, G D ^a   Singh, S N ^a   McAreavey, D ^a   Shelton, B J ^a   Exner, D V ^a  

^a NONE   (Canada)

Author keywords

Bypass; Death, sudden; Mortality; Ventricles

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; ENALAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 0035949712     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3801.096335     Document Type: Article

References (31)

1. Clinical classification of cardiac deaths
2. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment
3. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases
4. Cardiac findings associated with sudden death secondary to atherosclerotic coronary artery disease: Comparison of patients with and those without previous angina pectoris and/or healed myocardial infarction
5. Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death
6. Arteriosclerosis of coronary arteries in sudden, unexpected deaths
7. Angiographic findings and prognostic indicators in patients resuscitated from sudden cardiac death
8. Role of myocardial revascularization in sudden cardiac death
9. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: A report from the Coronary Artery Surgery Study
10. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris
11. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery: Coronary Artery Bypass Graft (CABG) Patch Trial Investigators
12. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian Implantable Defibrillator Study
13. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias: AV1D Investigators Antiarrhythmics Versus Implantable Defibrillators
14. Implantable cardioverter defibrillator therapy: The sickest patients benefit the most
15. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure: The SOLVD Investigators
16. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions: The SOLVD Investigators
17. Studies of left ventricular dysfunction (SOLVD)-rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction
18. Regression models and lifetables
19. A randomized trial of coronary artery bypass surgery: Survival of patients with a low ejection fraction
20. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function
21. Effect of aortocoronary saphenous vein bypass grafting on death and sudden death: Comparison of nonrandomized medically and surgically treated cohorts with comparable coronary disease and left ventricular function
22. Mechanisms of death in the Coronary Artery Bypass Graft Patch trial: A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery
23. The Coronary Artery Bypass Graft (CABG) Patch Trial: The CABG Patch Trial Investigators and Coordinators
24. Sudden cardiac death
25. The effect of acute ischemia on transmembrane potentials in the intact heart: Relation to re-entry mechanisms
26. Cardiac Arrest and Sudden Cardiac Death
27. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome
28. Interobserver discordance in the classification of mechanisms of death in studies of heart failure
29. Dead is dead: Artificial definitions are no substitute
30. A comparison of observational studies and randomized, controlled trials
31. Randomized, controlled trials, observational studies, and the hierarchy of research designs